Chao Ma

April 22, 2024

Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD

Abstract Research indicates that there are links between m6A, m5C and m1A modifications and the development of different types of…

August 21, 2023

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy

Abstract Background: KIAA1429, also known as VIRMA (vir-like m6A methyltransferase associated), plays a crucial role in tumorigenesis by modulating the…

July 24, 2023

Identifying the oncogenic roles of FAP in human cancers based on systematic analysis

Abstract Background: Fibroblast activation protein-α (FAP) is a specific marker of cancer-associated fibroblasts (CAFs) and plays a crucial role in…